Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co IncfiledCriticalHisamitsu Pharmaceutical Co Inc
Priority to JP49046807ApriorityCriticalpatent/JPS5826353B2/ja
Publication of JPS50137996ApublicationCriticalpatent/JPS50137996A/ja
Publication of JPS5826353B2publicationCriticalpatent/JPS5826353B2/ja
A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof
Desilylative activation of TMSCN in chemoselective Strecker–Ugi type reaction: Functional fused imidazoles as building blocks as an entry route to annulated purines